Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
254 Leser
Artikel bewerten:
(1)

Equity Multiple Inc: EquityMultiple Raises Alpine Note Rates Amid Continued Investor Enthusiasm

Finanznachrichten News

NEW YORK, NY / ACCESSWIRE / May 20, 2024 / EquityMultiple, a leading real estate investment platform, today announced a rate increase for its popular cash management investment vehicle, the Alpine Note. This strategic move comes in response to the Federal Reserve's recent comments suggesting a "higher for longer" interest rate environment, providing investors with an opportunity to lock in a meaningful spread above T-bills.



As of May 16th, EquityMultiple increased the rate on its popular Alpine Notes to the following:

  • 3-month Notes: 6.10% APY
  • 6-month Notes: 7.15% APY
  • 9-month Notes: 7.50% APY

As of May 15th, the 9-month Alpine Note features an APY around 300 basis points higher than the 10-year treasury notes.

As interest rates continue to hover at elevated levels, the Federal Reserve's indications suggest that rate cuts are not on the immediate horizon. This environment presents a unique opportunity for investors to capitalize on higher yields. By increasing rates for the Alpine Note, EquityMultiple aims to offer its investors a compelling alternative to traditional T-bills, with the potential for enhanced returns in a stable and secure investment vehicle.

Remarked CEO Charles Clinton, "Our decision to raise rates for the Alpine Note is driven by our commitment to providing excellent investment opportunities as this new phase of the cycle plays out. With recent remarks from the Fed, it really feels like a 'higher for longer' environment, but nothing is for certain. In a fluid interest rate environment, we wanted to give investors the opportunity to lock in attractive rates on our Alpine Notes for the coming months. We are dedicated to helping our investors navigate this environment effectively and providing a range of real estate investment options to diversify for both fixed income and upside."

In addition to these standard 3, 6, and 9-month Notes, EquityMultiple also currently offers the Alpine Note Basecamp, a 3-month note paying a 9% APY with just a $1K minimum, a way for EquityMultiple investors to dip their toe in the water with respect to alternative asset investing.

Ongoing Success and Popularity of Alpine Notes

The Alpine Note has demonstrated significant success since its inception, raising over $200 million in investor capital. Notably, the investment vehicle has maintained a flawless track record, with no defaults or missed payments to date. This achievement underscores EquityMultiple's commitment to delivering reliable and high-performing investment options to self-directed individual investors.

EquityMultiple's rate increase for the Alpine Note aligns with the company's broader strategy of leveraging market conditions to benefit its investors. By offering a higher yield, EquityMultiple continues to position the Alpine Note as a premier choice for cash management, catering to investors seeking both security and attractive returns.

"The success of the Alpine Note, coupled with its impeccable performance record, makes it a standout investment vehicle," said Marious Sjlusen, Chief Investment Officer at EquityMultiple. "As we navigate this period of elevated interest rates, we are committed to providing our investors with opportunities that offer meaningful spreads and align with their financial goals."

About EquityMultiple

EquityMultiple is a leading investment management and technology firm whose mission is to provide unique real estate private equity and private credit opportunities to accredited investors. EquityMultiple's network of 50,000 investors has participated in over $5 billion in commercial real estate transactions since 2015. The firm partners with experienced real estate operators in strong markets across the country and offers investments in both individual properties and funds through its innovative platform.

For more information, please visit https://www.equitymultiple.com.

Contact Information

Jessica Lombao
jessica.lombao@issuerdirect.com

SOURCE: EquityMultiple

.

View the original press release on newswire.com.

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.